Fortress Biotech, Inc. (FBIO)

Fortress Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 2, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	44	55	71	249	301	182
Market Cap Growth	0.19%	-23.29%	-71.44%	-17.12%	65.21%	273.18%
Enterprise Value	61	26	28	219	243	206
Last Close Price	1.54	3.01	9.82	37.50	47.55	38.55
PS Ratio	0.55	0.65	0.94	3.62	6.59	4.97
PB Ratio	1.89	34.39	1.42	1.10	1.53	2.51
P/TBV Ratio	11.69	24.21	4.90	2.59	3.51	9.66
EV/Sales Ratio	1.06	0.31	0.37	3.18	5.34	5.62
Debt / Equity Ratio	-5.61	55.82	2.59	0.33	0.45	1.59
Asset Turnover	0.59	0.37	0.22	0.19	0.16	0.20
Inventory Turnover	7.51	10.90	13.79	28.57	69.62	13.72
Quick Ratio	0.99	1.13	1.62	3.26	4.99	3.32
Current Ratio	1.23	1.38	1.80	3.43	5.14	3.43
Return on Equity (ROE)	-	-597.36%	-155.06%	-77.95%	-76.42%	-220.34%
Return on Assets (ROA)	-38.05%	-37.68%	-36.84%	-30.65%	-21.05%	-37.70%
Return on Capital (ROIC)	-88.40%	-64.54%	-52.98%	-38.12%	-24.87%	-48.28%
Earnings Yield	-131.47%	-111.11%	-121.69%	-25.98%	-15.48%	-21.97%
FCF Yield	-240.52%	-235.07%	-255.99%	-48.62%	-28.49%	-53.49%
Buyback Yield / Dilution	-144.73%	-36.89%	-8.78%	-13.46%	-31.61%	-25.88%

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q